Digital Tools in Pharmacy for Capturing Adverse Events and Complaints Digital Tools in Pharmacy for Capturing Adverse Events and Complaints Context In the evolving landscape of healthcare, the importance of regulatory affairs compliance in pharmacy practice cannot be overstated. Regulatory Affairs (RA) plays a critical role in ensuring that all pharmaceutical products are safe, effective, and properly labeled as they transition through the lifecycle from development to market. With heightened regulatory scrutiny, particularly surrounding medication safety regulations, effective strategies must be employed to capture adverse events (AEs) and complaints within both hospital and community pharmacy settings. The rise of digital…

Ensuring Consistency Between Pharmacy Systems and Official Product Information Ensuring Consistency Between Pharmacy Systems and Official Product Information In the evolving landscape of pharmaceutical regulation, the interaction between pharmacy practices, regulatory affairs (RA), and pharmacovigilance (pharmacovig) is paramount to ensuring medication safety and compliance with regulations. Regulatory Affairs professionals must understand the implications of pharmacy system operations and how they align with the official product information provided to healthcare professionals and patients. This article will explore the regulatory context, relevant guidelines, documentation expectations, review and approval flows, and common deficiencies related to ensuring consistency between pharmacy systems and official product…

PV and RA Expectations for Pharmacy-Led Clinical Services and Vaccinations PV and RA Expectations for Pharmacy-Led Clinical Services and Vaccinations Context In the evolving landscape of healthcare, pharmacy-led clinical services and vaccinations have become integral components in the delivery of patient care. Regulatory Affairs (RA) and Pharmacovigilance (PV) play vital roles in ensuring that these services comply with robust safety and efficacy standards. As pharmacy professionals engage more deeply with clinical services, it is essential to understand the regulations and guidelines that govern pharmacovigilance and how they interface with regulatory expectations in the United States and Europe. Legal/Regulatory Basis The…

Handling Off-Label Use Observed in Pharmacy Settings: Reporting and Governance Handling Off-Label Use Observed in Pharmacy Settings: Reporting and Governance Off-label drug use refers to the prescription of pharmaceutical products for unapproved indications or patient populations that differ from the specifications outlined in product labeling. While off-label use can be an essential aspect of clinical practice, especially in therapeutic areas where treatment options are limited, it presents significant challenges in regulatory affairs (RA), pharmacovigilance (PV), and compliance frameworks. This article provides a structured explanation of the regulations, guidelines, and agency expectations regarding off-label use, embedding the context within pharmacy settings,…

Pharmacy Participation in RWE and Registries Linked to Regulatory Outcomes Pharmacy Participation in RWE and Registries Linked to Regulatory Outcomes Pharmacy practice increasingly intersects with Regulatory Affairs (RA) and its obligations regarding Real-World Evidence (RWE) and registries. As healthcare continues to evolve, pharmacy stakeholders must navigate a complex regulatory landscape to ensure compliance and optimize regulatory outcomes. This article serves as a comprehensive guide for Regulatory Affairs, Chemistry, Manufacturing, and Controls (CMC), and labeling teams operating within the US, UK, and EU contexts. Context Real-World Evidence refers to the clinical evidence derived from data relating to patient health status and…

Feedback Loops from Pharmacists into Risk Management Plans and REMS Feedback Loops from Pharmacists into Risk Management Plans and REMS Pharmacovigilance is a critical component in ensuring medication safety and efficacy throughout a drug’s lifecycle. As the landscape of healthcare continues to evolve, the role of pharmacists in contributing valuable feedback into Risk Management Plans (RMPs) and Risk Evaluation and Mitigation Strategies (REMS) has gained increasing importance. This article aims to provide an in-depth regulatory explainer on how pharmacovigilance systems interface with pharmacy practice, elucidating relevant regulations, guidelines, and agency expectations across the US, UK, and EU. Regulatory Context Pharmacovigilance…

Privacy and Consent Considerations in Pharmacy-Based Safety Data Collection Privacy and Consent Considerations in Pharmacy-Based Safety Data Collection Context In the evolving landscape of healthcare, pharmacy-based safety data collection has emerged as a critical component of both clinical and post-marketing surveillance activities. Regulatory Affairs (RA) professionals are tasked with ensuring that these collections occur within the frameworks established by various governing bodies such as the FDA in the United States, the EMA in the European Union, and the MHRA in the United Kingdom. Understanding the nuances of privacy and consent in this context is paramount for compliance and the protection…

Global and Local Policy Trends Strengthening Pharmacy–PV Interfaces Global and Local Policy Trends Strengthening Pharmacy–PV Interfaces The interplay between pharmacy practice and pharmacovigilance (PV) has become increasingly significant as global healthcare regulations adapt to enhance medication safety. This article aims to elucidate the frameworks governing these interactions, including the relevant regulations, guidelines, and agency expectations in the United States (US), United Kingdom (UK), and European Union (EU). Regulatory Affairs (RA) professionals, Continuous Manufacturing (CMC), and labelling teams must understand these interfaces to ensure compliance with local and global standards. Regulatory Affairs Context Regulatory Affairs (RA) is a pivotal function within…

Templates for Pharmacy–PV Collaboration Procedures and Agreements Templates for Pharmacy–PV Collaboration Procedures and Agreements Context In the ever-evolving landscape of pharmaceutical and biopharmaceutical industries, the interfaces between pharmacy practice, regulatory affairs (RA), and pharmacovigilance (PV) are becoming increasingly critical. Regulatory and compliance consulting has emerged as a vital service to ensure organizations meet the stringent regulations and guidelines put forth by key authorities including the FDA, EMA, and MHRA. Healthcare organizations, including hospital and community pharmacies, must engage in effective collaboration with their PV teams to comply with medication safety regulations. The integration of pharmacy practice within the broader regulatory…

Future Directions: Pharmacies as Key Nodes in Safety and Regulatory Ecosystems Future Directions: Pharmacies as Key Nodes in Safety and Regulatory Ecosystems The evolving landscape of pharmacy practice presents both challenges and opportunities for professionals engaged in regulatory affairs, especially in the context of ensuring compliance with medication safety regulations. Pharmacies have emerged as crucial nodes in the regulatory framework surrounding medication safety, requiring robust knowledge among Regulatory Affairs (RA) professionals to navigate complex guidelines, regulations, and agency expectations. Context As integral components of the healthcare system, pharmacies are responsible for not only dispensing medications but also ensuring their safe…